Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer
Abstract Background: IGFL1, a member of the insulin growth factor-like family, plays a potential role in tumorigenesis. This study aimed…